Author

C. Peano

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. Aghemo· 1 shared A. Lleo· 1 shared A. Termanini· 1 shared B. Franceschini· 1 shared C. Carretta· 1 shared C. Chiereghin· 1 shared C. Soldani· 1 shared D. Dimitri· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Aghemo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defineshyperactivated Tregs as a potential therapeutic target

G. Alvisi, A. Termanini, C. Soldani, F. Portale, R. Carriero, K. Pilipow, M. Polidoro, B. Franceschini, I. Malenica, S. Puccio, V. Lise, V. Zanon, F. S. Colombo, M. Tufano, C. Peano, , A. Lleo

This study identifies hyperactivated Tregs in iCCA as a therapeutic target through multimodal single-cell profiling of immune infiltrates.

bioRxiv · Mar 6, 2022Immunology

Mutated clones driving leukemic transformation are already detectable at the single cell level in CD34-positive cells in the chronic phase of primary myelofibrosis

S. Parenti, S. Rontauroli, C. Carretta, S. Mallia, E. Genovese, C. Chiereghin, C. Peano, L. Tavernari, E. Bianchi, S. Fantini, S. Sartini, O. Romano, S. Bicciato, E. Tagliafico, M. G. DELLA PORTA, R. MANFREDINI

The paper uses single cell genomics and transcriptomics to analyze CD34-positive cells in a PMF patient, identifying early mutations and clonal evolution associated with AML transformation.

bioRxiv · Dec 7, 2020Cancer Biology